Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03701763 · COMPLETED
Trial details
- NCT number
- NCT03701763
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2022-04-25
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.